Advertisement
Business
Subscribe to Business

The Lead

Sagent Pharmaceuticals Announces Leadership Changes

March 27, 2015 8:10 am | News | Comments

The Board of Directors of Sagent Pharmaceuticals has announced that Jeffrey Yordon, Chairman and Chief Executive Officer, has informed the Board of his decision to retire from the company.

Potential Billion-Dollar Verdict Rests on Disputed Deadline

March 27, 2015 8:00 am | by ADAM BEAM, Associated Press | News | Comments

What does it cost to miss a deadline? For the company that makes the prescription painkiller...

Dow Chemical, Olin in $5B Cash-and-Stock Deal

March 27, 2015 7:53 am | News | Comments

Dow Chemical is breaking off a significant portion of its chlorine operations in a deal valued...

Recipharm and Adroit Science Form Collaboration to Expand Service Offering

March 26, 2015 3:53 pm | News | Comments

Recipharm AB and Adroit Science AB have announced the formation of a new strategic collaboration...

View Sample

FREE Email Newsletter

Report: Sepsis Treatment Market to Dramatically Expand Following 2016 Drug Debut

March 26, 2015 3:33 pm | by Andy Szal, Digital Reporter | News | Comments

A new report expects the market value for sepsis treatments to increase more than thirteen-fold between 2016 and 2021 following the launch of a new sepsis-specific drug.

Genentech Announces Plans to Expand Hillsboro Facility

March 26, 2015 3:26 pm | News | Comments

Genentech, a member of the Roche Group, has announced plans to invest more than $125 million for the expansion of its fill/finish facility in Hillsboro, Oregon.

Shire and Cincinnati Children's Establish Rare Disease Research Collaboration

March 26, 2015 8:17 am | News | Comments

The goal of the collaboration is to discover and develop novel therapies to treat rare diseases with high unmet medical need combining Shire's development and commercialization capabilities with Cincinnati Children's research expertise.

Advertisement

Capsugel Investing More Than $25M in Increased Production Capacity and Quality Enhancements

March 26, 2015 7:59 am | News | Comments

Capsugel has announced that the company is investing more than $25 million to increase production capacity and deliver further quality enhancements for its vegetarian capsules.

AstraZeneca to Collaborate With the Harvard Stem Cell Institute in Diabetes

March 25, 2015 8:45 am | News | Comments

AstraZeneca has entered into a five-year research collaboration with the Harvard Stem Cell Institute (HSCI) to adapt a technique that creates human beta cells from stem cells for use in screens of AstraZeneca’s compound library in the search for new treatments for diabetes.

Managing the SUS-Based Facility Design

March 25, 2015 8:31 am | by Jeff Odum, CPIP, IPS-Integrated Project Services, Inc. | Blogs | Comments

There are many nuances that require a more focused approach to risk identification and project management for the “new” manufacturing facilities implementing Single-use Systems (SUS). 

Justices to Hear Arguments Over EPA Mercury Limits

March 25, 2015 8:18 am | by MARK SHERMAN, Associated Press | News | Comments

The Supreme Court is taking up a challenge by industry groups and Republican-led states that want to roll back Obama administration environmental rules aimed at reducing power plant emissions of mercury and other hazardous air pollutants that contribute to respiratory illnesses, birth defects and developmental problems in children.

Merck Board OKs Additional $10B Stock Buyback Plan

March 25, 2015 8:15 am | News | Comments

Merck & Co. says its board approved the repurchase of up to $10 billion more of its stock. The company said that amount will be added to the $1.7B remaining available for repurchase under a prior authorization.

Advertisement

Sun Pharma Announces Closure of Merger Deal with Ranbaxy

March 25, 2015 8:11 am | News | Comments

Sun Pharma today, begins the integration of Ranbaxy's business following the successful closure of its merger.  The integration, planned by Sun Pharma over many months, will focus on supporting strong growth.

Lycera Announces Milestone in Merck Collaboration

March 25, 2015 8:04 am | News | Comments

Lycera Corp. today announced the achievement of a milestone under the Company's collaboration agreement with Merck, known as MSD outside the United States and Canada, triggering an undisclosed payment.

GOP Hits Medicaid to Offset Doctor Fee Hikes

March 24, 2015 8:35 am | by DAVID ESPO, AP Special Correspondent | News | Comments

House Republicans quietly deepened recommended budget savings from the government's chief health care program for the poor by about $140 billion in recent weeks to offset part of the cost of higher payments to doctors who treat Medicare patients, according to officials familiar with the tradeoff.

BMS Acquires Exclusive License from Novo Nordisk for a Discovery Research Program Focused on Autoimmune Diseases

March 24, 2015 8:16 am | News | Comments

Bristol-Myers Squibb Company has signed an agreement with Novo Nordisk under which Bristol-Myers Squibb will acquire an exclusive global license to a discovery biologics research program focused on modulating the innate immune system as a therapy for autoimmune diseases.

FDA Warns Cosmetics Companies Against Promises That 'Go Too Far'

March 24, 2015 8:04 am | by Andy Szal, Digital Reporter | News | Comments

The agency said its tracking of claims by cosmetics companies during recent years indicated a proliferation in drugs claims--defined by the FDA as "intended to treat or prevent disease, or change the body’s structure or functions"--on product packaging and in web advertising.

Advertisement

WHO Denies Politics Swayed Ebola Emergency Declaration

March 23, 2015 4:14 pm | by MARIA CHENG, Associated Press; RAPHAEL SATTER, Associated Press | News | Comments

The World Health Organization denied that politics swayed the decision to declare an international emergency over the spread of the Ebola virus last year, despite evidence senior staffers repeatedly discussed the diplomatic and economic fallout of such a move.

ImmunoGen Lands Licensing Deal with Takeda

March 23, 2015 4:08 pm | by The Associated Press | News | Comments

Takeda will use ImmunoGen's technology to develop cancer treatments. ImmunoGen will get $20 million upfront and is eligible for milestone payments potentially totaling up to $210 million, plus royalties on sales.

Teva Announces New Head of Business Development, Strategy and Innovation

March 23, 2015 4:05 pm | News | Comments

Teva Pharmaceutical Industries has announced the appointment of Timothy R. Wright to the Company’s executive leadership team, heading business development, strategy and innovation.

Report Finds Pharmaceutical Industry Increased Its Impact on Global Economy

March 23, 2015 8:30 am | by Andy Szal, Digital Reporter | News | Comments

A recent report found the pharmaceutical industry increased its contribution to the global economy between 2006 and 2012.

Academic Research Added More than $1 Trillion to U.S. Economy

March 23, 2015 8:25 am | by Andy Szal, Digital Reporter | News | Comments

Over nearly two decades, inventions and products licensed by academic institutions contributed more than $1 trillion to the U.S. economy, according to a recent report from the Biotechnology Industry Organization.

Pfizer And Lilly Preparing To Resume Phase 3 Chronic Pain Program For Tanezumab

March 23, 2015 8:07 am | News | Comments

Pfizer and Eli Lilly announced today that they are preparing to resume the Phase 3 clinical program for tanezumab. As a result, Pfizer expects to receive a $200 million upfront payment from Lilly in accordance with their collaboration agreement.

Coronado Biosciences Announces the Formation of Mustang Therapeutics

March 20, 2015 8:17 am | News | Comments

Coronado Biosciences has announced the formation of a new company, Mustang Therapeutics, Inc. Mustang will initially focus on the preclinical and clinical development, as well as commercialization of proprietary Chimeric Antigen Receptor (CAR-T) technology.

Evotec and Sanofi Sign Agreement for Major Multi-Component Strategic Alliance

March 20, 2015 8:05 am | News | Comments

Evotec AG today announced that a definitive agreement for a major multi-component strategic alliance over the next five years has been signed with Sanofi. The transaction is expected to close on 31 March 2015.

Pharmaceutical, Biotech Mergers Set Record in 2014

March 19, 2015 1:42 pm | by Andy Szal, Digital Reporter | News | Comments

Mergers and acquisitions in the pharmaceutical and biotechnology sectors set a record in 2014, according to a report by Evaluate Ltd.

Daiichi Sankyo Signs Agreement with AstraZeneca to Co-Commercialize MOVANTIK in the US

March 19, 2015 8:18 am | News | Comments

Under the terms of the agreement, Daiichi Sankyo will pay a $200M up-front fee and subsequent sales-related payments of up to $625M. AstraZeneca will be responsible for manufacturing, will book all sales and will make sales-related commission payments to Daiichi Sankyo.

Report: U.S. Market for Asthma Treatment to See Modest Growth

March 19, 2015 8:09 am | by Andy Szal, Digital Reporter | News | Comments

The analysis by New York-based GBI Research predicted the recent expiration of patents for several of the top current therapeutics--most notably Singulair, Advair and Symbicort--would allow generic versions to curb market growth.

Herbalife Pyramid-Scheme Suit Dismissed

March 18, 2015 4:12 pm | News | Comments

A judge has dismissed a lawsuit by Herbalife shareholders who claimed that the business structure and marketing practices of the weight loss and nutritional supplements company violated the law and that they lost money in what amounts to a pyramid scheme.

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading